Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellbxhealth Plc ADR (OP:ANPCY)

0.0670 UNCHANGED
Last Price Updated: 2:45 PM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cellbxhealth Plc ADR

< Previous 1 2 3 4 5 6 Next >
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / February 18, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Potential in Immunotherapy Treatment Selection
PEER-REVIEWED PUBLICATION HIGHLIGHTS POTENTIAL FOR PARSORTIX SYSTEM IN IMMUNOTHERAPY TREATMENT SELECTION Parsortix isolation of CTCs highlights relationship between PD-L1 expression and epithelial to... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Concordance of Parsortix with tissue biopsy
BREAKTHROUGH STUDY DEMONSTRATES FOR THE FIRST TIME CONCORDANCE OF PARSORTIX LIQUID BIOPSY BLOOD TEST WITH INVASIVE TISSUE BIOPSY OF THE METASTATIC SITE Study explores key unmet medical need for... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Update on Lab Accreditation and Ovarian Study
First submissions made in relation to accreditation of ANGLE clinical laboratories Ovarian cancer study sample analysis slower than planned GUILDFORD, SURREY / ACCESSWIRE / January 13, 2022 / ANGLE plc... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Insight into Drug Resistance in NSCLC
EPIGENETIC ALTERATIONS IN GENES FROM LIQUID BIOPSIES PROVIDE INSIGHT INTO DRUG RESISTANCE IN NON-SMALL LUNG CANCER PATIENTS Longitudinal analysis of paired samples of CTCs and ctDNA shows important... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / December 22, 2021 /ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / December 1, 2021 / ANGLE plc ("ANGLE" or the "Company")(AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company,... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Parsortix in RNA analysis of CTCs as tool in NSCLC
ANGLE'S PARSORTIX SYSTEM KEY TO STUDY DEMONSTRATING RNA ANALYSIS OF CTCs AS A PROGNOSTIC TOOL IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS Research published by world-class cancer research centre... 
From ANGLE plc
Via AccessWire
Topics Death Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / November 26, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / November 17, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of LTIP Options and Share Options
Issue of LTIP Options and Share Options and adjustment in timescales for certain existing share options GUILDFORD, UK / ACCESSWIRE / November 15, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Appointment of Chief Medical Officer
Todd Druley, M.D., PhD. brings deep experience of building a medical team and establishing oncology assays, most recently at ArcherDX, Inc. Dr Druley is a physician-scientist, board-certified... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Issue of Equity Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / November 12, 2021 / ANGLE plc (AIM: AGL) (OTCQX:ANPCY), a world-leading liquid biopsy company, announces... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Participation at Jefferies healthcare conference
PARTICIPATION AT JEFFERIES LONDON HEALTHCARE CONFERENCE GUILDFORD, UK / ACCESSWIRE / November 12, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Parsortix System Showcased at NCRI Festival
Study in metastatic prostate cancer presented at NCRI Festival demonstrates longitudinal analysis of CTCs harvested using the Parsortix system is predictive of treatment response KLK2 gene expression... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Issue of Equity Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / November 10, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Change of Adviser
GUILDFORD, SURREY / ACCESSWIRE / November 2, 2021 / ANGLE plc ("the Company") Change of advisers ANGLE plc (OTCQX:ANPCY)(AIM:AGL), a world-leading liquid biopsy company, is pleased to announce the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / October 21, 2021 / ANGLE plc (AIM:AGL) (OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / October 15, 2021 / ANGLE plc (AIM:AGL) (OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
GUILDFORD, SURREY / ACCESSWIRE / September 30, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Interim Results
Interim Results for the six months ended 30 June 2021 - FDA Review Progressing With Response Anticipated in the Second Half of the Year - Successful Launch of Global Pharma Services Business - Ovarian... 
From ANGLE plc
Via AccessWire
News headline image
Angle PLC Announces Parsortix Demonstrates Ability to Isolate CTCs
PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM GENE ANALYSIS REVEALING MULTIPLE PROGNOSTIC BIOMARKERS Leading European study centre presents results of three studies in ovarian... 
From ANGLE plc
Via AccessWire
Topics Death Intellectual Property
News headline image
Angle PLC Announces Study Shows Use of Parsortix to Assess PD-L1
Study demonstrates use of Parsortix to assess PD-L1 Status of CTCs in Non-Small Cell Lung Cancer patients with a simple blood test Further evidence supporting ANGLE's decision to develop a... 
From ANGLE plc
Via AccessWire
Topics Death Intellectual Property
News headline image
Angle PLC Announces Parsortix Enables Gene Expression Analysis in mPCa
PARSORTIX SYSTEM ENABLES GENE EXPRESSION ANALYSIS IN METASTATIC PROSTATE CANCER PATIENTS Parsortix able to isolate CTCs in 80% of patients providing access to tumour material for gene expression... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Notice of Interim Results and Webcast
GUILDFORD, SURREY / ACCESSWIRE / September 7, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 30 June 2021... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Director/PDMR Shareholding
ANGLE plc ('ANGLE' or the 'Company') Director/PDMR Shareholding Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / August 24, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC - Study Highlights Superior Performance of Parsortix
PUBLICATION HIGHLIGHTS EASE OF USE AND SUPERIOR PERFORMANCE OF PARSORTIX SYSTEM IN HARVESTING CTCs FROM METASTATIC BREAST CANCER PATIENTS Quantity, purity and quality of CTCs captured using the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / August 6, 2021 / ANGLE plc (AIM:AGL) (OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Issue of Equity
Exercise of Options and Total Voting Rights GUILDFORD, SURREY / ACCESSWIRE / August 3, 2021 / ANGLE plc (OTCQX:ANPCY) (AIM:AGL), a world-leading liquid biopsy company, announces that following the... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
News headline image
Angle PLC Announces Contract Secured For Bespoke Assay Development
ANGLE to develop two custom CTC assays to look at biomarkers of DNA damage repair Validated assays expected to be used for longitudinal analysis in clinical trial GUILDFORD, SURREY / ACCESSWIRE / July... 
From ANGLE plc
Via AccessWire
Topics Intellectual Property
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.